NasdaqCM - Delayed Quote USD

Check-Cap Ltd. (CHEK)

2.1900 +0.1400 (+6.83%)
At close: 4:00 PM EDT
2.2500 +0.06 (+2.74%)
After hours: 7:36 PM EDT
Loading Chart for CHEK
DELL
  • Previous Close 2.0500
  • Open 2.1700
  • Bid --
  • Ask --
  • Day's Range 2.0520 - 2.2000
  • 52 Week Range 1.3300 - 4.6250
  • Volume 13,676
  • Avg. Volume 264,973
  • Market Cap (intraday) 12.81M
  • Beta (5Y Monthly) 0.21
  • PE Ratio (TTM) --
  • EPS (TTM) -3.0100
  • Earnings Date Jul 30, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

www.check-cap.com

85

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CHEK

Performance Overview: CHEK

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CHEK
5.29%
S&P 500
10.00%

1-Year Return

CHEK
53.15%
S&P 500
27.22%

3-Year Return

CHEK
91.31%
S&P 500
27.58%

5-Year Return

CHEK
95.02%
S&P 500
86.59%

Compare To: CHEK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHEK

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    12.75M

  • Enterprise Value

    -15.29M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.47

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -28.62%

  • Return on Equity (ttm)

    -48.74%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -17.62M

  • Diluted EPS (ttm)

    -3.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.07M

  • Total Debt/Equity (mrq)

    0.11%

  • Levered Free Cash Flow (ttm)

    -12.62M

Research Analysis: CHEK

Company Insights: CHEK

Research Reports: CHEK

People Also Watch